Clinical trial
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)
NCT00035815 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- December 31, 2007
- Enrollment
- 330 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.